Pretax income is the income that a company earns before paying income taxes. Zeo ScientifiX's pretax income for the
three
months ended in Jan. 2025 was $-1.24 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Jan. 2025 was $-4.91 Mil.
Zeo ScientifiX's pretax margin was -114.04%.
During the past 13 years, Zeo ScientifiX's highest Pretax Margin was -101.84%. The lowest was -1598.77%. And the median was -291.74%.
Zeo ScientifiX Pre-Tax Income Historical Data
The historical data trend for Zeo ScientifiX's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Zeo ScientifiX's Pre-Tax Income
For the Biotechnology subindustry, Zeo ScientifiX's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zeo ScientifiX's Pre-Tax Income Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zeo ScientifiX's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Zeo ScientifiX's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Jan. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-4.91 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zeo ScientifiX (OTCPK:ZEOX) Pre-Tax Income Explanation
Zeo ScientifiX's Pretax Margin for the quarter that ended in Jan. 2025 is calculated as
During the past 13 years, Zeo ScientifiX's highest Pretax Margin was -101.84%. The lowest was -1598.77%. And the median was -291.74%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zeo ScientifiX Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Zeo ScientifiX's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Zeo ScientifiX Inc is a clinical-stage biopharmaceutical company located inside Nova Southeastern University's Collaborative Center for Research in Davie, Florida. The Company is a clinical-stage biopharmaceutical company principally focusing on the development of biological therapeutics for the treatment of degenerative diseases and regenerative medicine. The Company's proprietary products, including Zofin, are derived from perinatal sources and manufactured to retain the naturally occurring extracellular vesicles, proteins and cell secreted nanoparticles and Patient Pure X (PPX ), an autologous biologic containing a nanoparticle fraction that is precipitated from a patient's own peripheral blood (RAAM Products).
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ZEOX has been successfully added to your 